Inhibition of ATR Overcomes Chemotherapy Resistance in p53 Deficient Myeloma Cells

被引：2
|
作者：
Bouard, Louise [1 ,2 ]
Tessoulin, Benoit [1 ]
Descamps, Geraldine [3 ]
Touzeau, Cyrille [1 ]
Moreau, Philippe [4 ]
Amiot, Martine [3 ]
Pellat-Deceunynck, Catherine [3 ]
机构：
[1] Nantes Univ Hosp, Clin Hematol, Nantes, France
[2] CRCINA, Nantes, France
[3] Univ Nantes, CNRS, CRCINA, INSERM, Nantes, France
[4] Univ Hosp Hotel Dieu, Clin Hematol, Nantes, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3109
引用
收藏
页数：3
相关论文
共 50 条
  • [31] P53 mutations and resistance to chemotherapy: A stab in the back for p73
    Soussi, T
    CANCER CELL, 2003, 3 (04) : 303 - 305
  • [32] P53 mutations and resistance to chemotherapy: a stab in the back for p73?
    Soussi, T
    BULLETIN DU CANCER, 2003, 90 (05) : 383 - 386
  • [33] Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
    Kraus, M.
    Bader, J.
    Overkleeft, H.
    Driessen, C.
    BLOOD CANCER JOURNAL, 2013, 3 : e103 - e103
  • [34] Pretreatment with thymoquinone overcomes 5-Fluorouracil-induced drug resistance in p53 mutant colorectal cancer cells
    Morgenthal, S.
    Poehlmann, A.
    Gali-Muhtasib, H.
    Roessner, A.
    Schneider-Stock, R.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 254 - 255
  • [35] ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy
    Kwok, Marwan
    Davies, Nicholas
    Agathanggelou, Angelo
    Smith, Edward
    Petermann, Eva
    Yates, Eliot
    Brown, Jeffrey
    Lau, Alan
    Stankovic, Tatjana
    BLOOD, 2014, 124 (21)
  • [36] Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
    M Kraus
    J Bader
    H Overkleeft
    C Driessen
    Blood Cancer Journal, 2013, 3 : e103 - e103
  • [37] Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma
    Herviou, Laurie
    Ovejero, Sara
    Izard, Fanny
    Karmous-Gadacha, Ouissem
    Gourzones, Claire
    Bellanger, Celine
    De Smedt, Eva
    Ma, Anqi
    Vincent, Laure
    Cartron, Guillaume
    Jin, Jian
    De Bruyne, Elke
    Grimaud, Charlotte
    Julien, Eric
    Moreaux, Jerome
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [38] RPA and ATR link transcriptional stress to p53
    Derheimer, Frederick A.
    O'Hagan, Heather M.
    Krueger, Heather M.
    Hanasoge, Sheela
    Paulsen, Michelle T.
    Ljungman, Mats
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (31) : 12778 - 12783
  • [39] Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma
    Laurie Herviou
    Sara Ovejero
    Fanny Izard
    Ouissem Karmous-Gadacha
    Claire Gourzones
    Celine Bellanger
    Eva De Smedt
    Anqi Ma
    Laure Vincent
    Guillaume Cartron
    Jian Jin
    Elke De Bruyne
    Charlotte Grimaud
    Eric Julien
    Jérôme Moreaux
    Clinical Epigenetics, 2021, 13
  • [40] p53 and other components of the DNA damage response as determinants of cell sensitivity to ATR inhibition
    Middleton, F. K.
    Chen, T.
    Pollard, J. R.
    Curtin, N. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S134 - S134
12345